Upgrade to SI Premium - Free Trial

Vanda Pharmaceuticals (VNDA) Misses Q4 EPS by 1c

February 12, 2013 7:31 AM
Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) reported Q4 EPS of ($0.23) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Earnings

Next Articles